Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art

Background: It is essential to determine the cut-off value of serum anti-Mullerian hormone (AMH) to predict the hyper response in assisted reproductive technology (ART). There are few studies mentioning the cut-off value for the hyper response in infertile women but not specifically for polycystic o...

Full description

Bibliographic Details
Main Authors: Radha Vembu, Nellepalli Sanjeeva Reddy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Human Reproductive Sciences
Subjects:
Online Access:http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2017;volume=10;issue=2;spage=91;epage=94;aulast=Vembu
id doaj-d0b4ef6b88cb4f388acf21017dec33fc
record_format Article
spelling doaj-d0b4ef6b88cb4f388acf21017dec33fc2020-11-25T00:52:30ZengWolters Kluwer Medknow PublicationsJournal of Human Reproductive Sciences0974-12081998-47662017-01-01102919410.4103/jhrs.JHRS_15_16Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in artRadha VembuNellepalli Sanjeeva ReddyBackground: It is essential to determine the cut-off value of serum anti-Mullerian hormone (AMH) to predict the hyper response in assisted reproductive technology (ART). There are few studies mentioning the cut-off value for the hyper response in infertile women but not specifically for polycystic ovary syndrome (PCOS) and non-PCOS groups. With this in background, this study was conducted. Aim: To determine the cut-off value of serum AMH to predict the hyper response in women with PCOS and non-PCOS undergoing a controlled ovarian stimulation (COS) in ART. Objective: To compare the outcome of stimulation in PCOS and non-PCOS groups. Materials and Methods: All 246 women enrolled for Intra Cytoplasmic Sperm Injection (ICSI) fulfilling the selection criteria were recruited. On the day 3 of the cycle, the serum AMH, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), estradiol and antral follicle count (AFC) were measured. They underwent COS as per the unit protocol. They were divided into PCOS and non-PCOS groups as per the Rotterdam’s criteria. The mean age, duration of infertility, Body Mass Index (BMI), Ovarian reserve markers and outcome of stimulation were compared. Using the Statistical Package for the Social Sciences version 16.0 software, the significant difference was measured by multivariate analysis, as well as a one-way analysis of variance with Tukey’s post-hoc test was used. Results: Among 246 women, 31.3% were in PCOS group, and 68.7% were in non-PCOS group. Comparison of PCOS and non-PCOS groups showed a significant difference in the age with the mean age being 29.2 and 31.5 years, respectively. The mean AMH and AFC were 2-fold higher in PCOS group. The mean number of follicles, oocytes retrieved, MII and oocytes fertilised were significantly higher in PCOS group. The pregnancy rate was 52.6% in PCOS and 30.9% in non-PCOS group. In the PCOS group, 22.1% had ovarian hyper stimulation syndrome (OHSS), and only 4.7% had OHSS in non-PCOS group (P = 0.0005). Receiving Operator Curve (ROC) curve was plotted to predict the hyper response, which showed a cut-off value of 6.85 ng/ml with a sensitivity of 66.7% and a specificity of 68.7% for PCOS group and 4.85 ng/ml with a sensitivity of 85.7% and a specificity of 89.7% in non-PCOS group. Conclusion: The cut-off value of serum AMH to predict the hyper response in PCOS group is 6.85 ng/ml and in non-PCOS group is 4.85 ng/ml.http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2017;volume=10;issue=2;spage=91;epage=94;aulast=VembuAnti-Mullerian hormonecontrolled ovarian stimulationhyper responsenon-PCOSPCOS
collection DOAJ
language English
format Article
sources DOAJ
author Radha Vembu
Nellepalli Sanjeeva Reddy
spellingShingle Radha Vembu
Nellepalli Sanjeeva Reddy
Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
Journal of Human Reproductive Sciences
Anti-Mullerian hormone
controlled ovarian stimulation
hyper response
non-PCOS
PCOS
author_facet Radha Vembu
Nellepalli Sanjeeva Reddy
author_sort Radha Vembu
title Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
title_short Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
title_full Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
title_fullStr Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
title_full_unstemmed Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in art
title_sort serum amh level to predict the hyper response in women with pcos and non-pcos undergoing controlled ovarian stimulation in art
publisher Wolters Kluwer Medknow Publications
series Journal of Human Reproductive Sciences
issn 0974-1208
1998-4766
publishDate 2017-01-01
description Background: It is essential to determine the cut-off value of serum anti-Mullerian hormone (AMH) to predict the hyper response in assisted reproductive technology (ART). There are few studies mentioning the cut-off value for the hyper response in infertile women but not specifically for polycystic ovary syndrome (PCOS) and non-PCOS groups. With this in background, this study was conducted. Aim: To determine the cut-off value of serum AMH to predict the hyper response in women with PCOS and non-PCOS undergoing a controlled ovarian stimulation (COS) in ART. Objective: To compare the outcome of stimulation in PCOS and non-PCOS groups. Materials and Methods: All 246 women enrolled for Intra Cytoplasmic Sperm Injection (ICSI) fulfilling the selection criteria were recruited. On the day 3 of the cycle, the serum AMH, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), estradiol and antral follicle count (AFC) were measured. They underwent COS as per the unit protocol. They were divided into PCOS and non-PCOS groups as per the Rotterdam’s criteria. The mean age, duration of infertility, Body Mass Index (BMI), Ovarian reserve markers and outcome of stimulation were compared. Using the Statistical Package for the Social Sciences version 16.0 software, the significant difference was measured by multivariate analysis, as well as a one-way analysis of variance with Tukey’s post-hoc test was used. Results: Among 246 women, 31.3% were in PCOS group, and 68.7% were in non-PCOS group. Comparison of PCOS and non-PCOS groups showed a significant difference in the age with the mean age being 29.2 and 31.5 years, respectively. The mean AMH and AFC were 2-fold higher in PCOS group. The mean number of follicles, oocytes retrieved, MII and oocytes fertilised were significantly higher in PCOS group. The pregnancy rate was 52.6% in PCOS and 30.9% in non-PCOS group. In the PCOS group, 22.1% had ovarian hyper stimulation syndrome (OHSS), and only 4.7% had OHSS in non-PCOS group (P = 0.0005). Receiving Operator Curve (ROC) curve was plotted to predict the hyper response, which showed a cut-off value of 6.85 ng/ml with a sensitivity of 66.7% and a specificity of 68.7% for PCOS group and 4.85 ng/ml with a sensitivity of 85.7% and a specificity of 89.7% in non-PCOS group. Conclusion: The cut-off value of serum AMH to predict the hyper response in PCOS group is 6.85 ng/ml and in non-PCOS group is 4.85 ng/ml.
topic Anti-Mullerian hormone
controlled ovarian stimulation
hyper response
non-PCOS
PCOS
url http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2017;volume=10;issue=2;spage=91;epage=94;aulast=Vembu
work_keys_str_mv AT radhavembu serumamhleveltopredictthehyperresponseinwomenwithpcosandnonpcosundergoingcontrolledovarianstimulationinart
AT nellepallisanjeevareddy serumamhleveltopredictthehyperresponseinwomenwithpcosandnonpcosundergoingcontrolledovarianstimulationinart
_version_ 1725242122499522560